Abstract
Breast cancer is a commonly encountered cancer in women. Tamoxifen is a frequently used drug in breast cancer. It is a selective estrogen receptor modulator (SERM). It is used for both chemoprevention and for palliative care in these patients. Drug-induced thrombocytopenia is a common diagnosis these days. Moreover, this condition can be life threatening or even fatal. It can either be due to increased platelet destruction or reduced formation. Either way, early diagnosis followed by discontinuation of the offending agent is the key to successful management. Here, we present a rare case of tamoxifen-induced thrombocytopenia.
| Original language | English |
|---|---|
| Pages (from-to) | 156-157 |
| Number of pages | 2 |
| Journal | Journal of Applied Pharmaceutical Science |
| Volume | 6 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 01-01-2016 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Medicine (miscellaneous)
- Pharmacology, Toxicology and Pharmaceutics(all)
- Pharmacology (medical)
Cite this
}
A rare case of tamoxifen-induced thrombocytopenia. / Pathak, Anurag; Kunder, Sushil Kiran; Avinash, A.; Patil, Navin; Rao, N. Karthik.
In: Journal of Applied Pharmaceutical Science, Vol. 6, No. 1, 01.01.2016, p. 156-157.Research output: Contribution to journal › Article
TY - JOUR
T1 - A rare case of tamoxifen-induced thrombocytopenia
AU - Pathak, Anurag
AU - Kunder, Sushil Kiran
AU - Avinash, A.
AU - Patil, Navin
AU - Rao, N. Karthik
PY - 2016/1/1
Y1 - 2016/1/1
N2 - Breast cancer is a commonly encountered cancer in women. Tamoxifen is a frequently used drug in breast cancer. It is a selective estrogen receptor modulator (SERM). It is used for both chemoprevention and for palliative care in these patients. Drug-induced thrombocytopenia is a common diagnosis these days. Moreover, this condition can be life threatening or even fatal. It can either be due to increased platelet destruction or reduced formation. Either way, early diagnosis followed by discontinuation of the offending agent is the key to successful management. Here, we present a rare case of tamoxifen-induced thrombocytopenia.
AB - Breast cancer is a commonly encountered cancer in women. Tamoxifen is a frequently used drug in breast cancer. It is a selective estrogen receptor modulator (SERM). It is used for both chemoprevention and for palliative care in these patients. Drug-induced thrombocytopenia is a common diagnosis these days. Moreover, this condition can be life threatening or even fatal. It can either be due to increased platelet destruction or reduced formation. Either way, early diagnosis followed by discontinuation of the offending agent is the key to successful management. Here, we present a rare case of tamoxifen-induced thrombocytopenia.
UR - http://www.scopus.com/inward/record.url?scp=84957631159&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84957631159&partnerID=8YFLogxK
U2 - 10.7324/JAPS.2016.600125
DO - 10.7324/JAPS.2016.600125
M3 - Article
AN - SCOPUS:84957631159
VL - 6
SP - 156
EP - 157
JO - Journal of Applied Pharmaceutical Science
JF - Journal of Applied Pharmaceutical Science
SN - 2231-3354
IS - 1
ER -